Lv11
70 积分 2022-02-18 加入
FDA Experience on CAR T Cell Pharmacokinetics/Pharmacodynamics and Model‐Based Assessments
2小时前
已完结
Mitigation of chromosome loss in clinical CRISPR-Cas9-engineered T cells
1年前
已完结
Frequent aneuploidy in primary human T cells after CRISPR–Cas9 cleavage
3年前
已完结
Regional CAR T cell therapy: An ignition key for systemic immunity in solid tumors
3年前
已完结
In vivo imaging of nanoparticle-labeled CAR T cells
3年前
已完结
Bioinstructive implantable scaffolds for rapid in vivo manufacture and release of CAR-T cells
3年前
已完结
A genome-scale screen for synthetic drivers of T cell proliferation
3年前
已完结
An NK-like CAR T cell transition in CAR T cell dysfunction
3年前
已完结
皖公网安备34019202002308
